BioSpace News Archive

Business

Galera Expands Commercial Leadership Team

Galera Therapeutics, Inc. today announced the appointment of accomplished pharmaceutical sales, market access, and commercial operations executives to Galera’s senior commercial leadership team, effective immediately.

May 1, 2023
·
11 min read
U.S. Food & Drug Administration Issues Complete Response Letter for TransCon™ PTH in Hypoparathyroidism

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has issued a complete response letter (CRL) for the TransCon PTH (palopegteriparatide) New Drug Application (NDA) for the treatment of adults with hypoparathyroidism.

May 1, 2023
·
6 min read
Business

Compugen to Release First Quarter 2023 Results on Monday, May 15, 2023

Compugen Ltd. today announced that the Company will release its first quarter 2023 financial results on Monday, May 15, 2023, before the U.S. financial markets open.

May 1, 2023
·
2 min read
BioForest

CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

CTI BioPharma Corp. today announced that two abstracts have been accepted for presentation at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6, 2023 in Chicago, IL.

May 1, 2023
·
2 min read
Biotech Bay

AN2 Therapeutics to Present at JMP Securities Life Sciences Conference

AN2 Therapeutics, Inc. today announced that Eric Easom, Co-Founder, President and CEO, will present at the JMP Securities Life Sciences Conference.

May 1, 2023
·
1 min read
Business

2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program

2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program.

May 1, 2023
·
6 min read
Business

Cognition Therapeutics Appoints John Doyle to the Role of Chief Financial Officer

Cognition Therapeutics, Inc. (Nasdaq: CGTX), today announced the appointment of John Doyle to the role of chief financial officer.

May 1, 2023
·
5 min read
Pharm Country

Anavex Life Sciences Announces Issuance of New U.S. Patent Expanding ANAVEX®2-73 (blarcamesine) Intellectual Property Portfolio for the Treatment of Hypertension

Anavex Life Sciences Corp. announced today it was granted a new U.S. Patent No. 11,622,955 entitled “SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY,” from the United States Patent and Trademark Office.

May 1, 2023
·
5 min read
Business

TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ended March 31, 2023.

May 1, 2023
·
18 min read
Pharm Country

Indaptus Therapeutics’ Chief Scientific Officer Michael Newman, Ph.D. Named a Chair of the 4th STING & TLR-Targeting Therapies Summit

Indaptus Therapeutics, Inc. announces the Company’s Chief Scientific Officer, Michael Newman, Ph.D., has been named chair for two of the three days of the 4th STING & TLR-Targeting Therapies Summit to be held in Boston on May 9-11, where he will also be a featured speaker.

May 1, 2023
·
8 min read